- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 8, 2026 | 10.09M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 8.27M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 1.97M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $55K |
| Capex | Q1 2026 · Mar 31, 2025 | $713K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$9.27M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$21.1M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $19.86M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $13.16M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $48.06M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$3.89M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$1.17M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $13.45M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $24.41M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $27.72M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $57.15M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $90.93M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $47.96M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $39.69M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $105.21M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $100.21M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.77 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$9.79 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.77 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$9.79 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $8.59M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $15.75M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $4.01M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $16.49M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$14.68M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$19.23M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$9.81M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$31.05M |
| Revenue | Q1 2026 · Mar 31, 2026 | $12.02M |
| Revenue | Q1 2026 · Mar 31, 2025 | $9.48M |